bmiMD vs Midi Health

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

bmiMD vs Midi Health: Overview

Choosing between bmiMD and Midi Health for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

bmiMD offers both semaglutide and tirzepatide at $129/month with a rating of 8/10. Midi Health also provides both semaglutide and tirzepatide at $164/month with a 8.6/10 rating.

With only a $35/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$35/mo
Rating Difference
0.6
Winner
Midi Health
Best For
Quality

bmiMD

View full bmiMD review →
Rating
8/10
Monthly Price
$129Cheaper
Medications
semaglutidetirzepatidemetformin

Pros

  • The full price ladder is published on the product page, not hidden behind a quiz: compounded semaglutide is $129 billed monthly, $119/mo on 3 months ($357), $109/mo on 6 months ($654) and $99/mo on 12 months ($1,188), checked July 26, 2026
  • You are not charged until a licensed provider confirms you are eligible. bmiMD authorises your card, releases the hold if you do not qualify, and states you 'won't incur any charges'
  • A 100% money-back guarantee if you are not approved for treatment, including the assessment
  • Unusually broad catalogue beyond GLP-1s: microdose semaglutide and tirzepatide, metformin from $19/mo, MIC + B12 from $69/mo, naltrexone/bupropion, sermorelin and NAD+
  • Free shipping on every subscription order and 24/7 clinician access included in the plan price
  • The compounded disclosure is explicit and specific, naming FDA-registered facilities while stating the drugs are not FDA-approved
  • Subscriptions can be cancelled or paused from your account rather than only by email

Cons

  • A $50 non-refundable cancellation fee applies if you cancel after your intake is approved but before the pharmacy processes the order - a charge most competitors do not levy
  • Once the prescription reaches the pharmacy, all sales are final: 'we do not offer refunds for partially used subscription periods'
  • The site runs constant price-increase pressure - a sitewide 'Prices increase soon, lock in today's rate before it goes up' banner, a 'Price increases in' countdown, 'LIMITED TIME' on every plan tier and 'Lock This Price Now' on every product
  • The homepage contradicts itself on tirzepatide, listing it at 'Starting as low as $149/mo' in one block and 'As low as $139/month' in another
  • The $99 headline requires committing to 12 months and paying $1,188 upfront; month to month is $129
  • This offer is not available in Alabama, Arkansas, California, Kentucky, Louisiana, Mississippi, North Carolina, North Dakota or South Carolina
  • No BBB profile and a relatively small Trustpilot sample mean limited independent history to check
  • No published customer phone number, and the compounded disclosure sits on product pages rather than the landing page
Choose bmiMD

Midi Health

View full Midi Health review →
Rating
8.6/10Better
Monthly Price
$164
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

  • The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
  • Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
  • Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
  • Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
  • There is no membership fee. You pay for care and medication only
  • Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
  • Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
  • The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
  • Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
  • Available in all 50 states

Cons

  • The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
  • Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
  • Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
  • Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
  • Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
  • Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
  • The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Choose Midi Health

Feature-by-feature comparison

FeaturebmiMDMidi Health
Monthly Price$129$164
Rating8/108.6/10
Medicationssemaglutide, tirzepatide, metformincompounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1s
Insurance AcceptedNoYes
Support Hours24/7 clinician access claimedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedFree shipping on subscription orders; timeframe not publishedDiscreet shipping included in every quoted medication price
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up Frequency24/7 clinician access with refills delivered on subscriptionContinued care visits with the same clinician, covered by insurance for qualifying patients
Money-back Guarantee100% refund if you are not approved for treatment; otherwise all sales are final once the prescription reaches the pharmacyNone published
Cancellation PolicyCancel or pause from your account any time, but a $50 non-refundable fee applies after intake approval and there are no refunds for partially used periodsNo membership fee and no subscription lock-in; you pay for care and medication only

Which should you choose?

Choose bmiMD if you:

  • Want to save $35/month with a more affordable option
  • Value: the full price ladder is published on the product page, not hidden behind a quiz: compounded semaglutide is $129 billed monthly, $119/mo on 3 months ($357), $109/mo on 6 months ($654) and $99/mo on 12 months ($1,188), checked july 26, 2026

Choose Midi Health if you:

  • Prefer a higher-rated service (8.6/10 vs 8/10)
  • Need insurance coverage for your treatment
  • Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Website previews

bmiMD

bmiMD website

Midi Health

Midi Health website

Our recommendation

Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Midi Health

Compare other providers

Compare GLP-1 Brands